SCHEMBL1153522

SCHEMBL1153522

CCOC(=O)C1(NC(=O)C(C)c2ccc(Cl)cc2OC)CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
LPAR1 Q92633 6/20 0.38
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.35
MAPT P10636 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1812607 0.81 LPAR1 (0.40) MEN1KMT2ALPAR1SMN1; SMN2MAPT
SCHEMBL7960240 0.81 LPAR1 (0.45) LPAR1
SCHEMBL7949836 0.81 LPAR1 (0.45) LPAR1
SCHEMBL7960904 0.81 LPAR1 (0.45) LPAR1
SCHEMBL7961786 0.79 LPAR1 (0.45) LPAR1
SCHEMBL16463001 0.78 OPRM1 (0.36) MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL4501238 0.78 ALDH1A1 (0.35) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL8704918 0.76 LPAR1 (0.45) LPAR1
SCHEMBL7964417 0.76 LPAR1 (0.45) LPAR1
SCHEMBL8703008 0.76 LPAR1 (0.45) LPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110092368-A1 2,4,6-Phenyl-substituted cyclic ketoenols FISCHER REINER 2011-04-21 US disclosed
US-7888285-B2 2,4,6-phenyl substituted cyclic ketoenols BAYER CROPSCIENCE AG (DE) 2011-02-15 US disclosed
US-20070015664-A1 2,4,6-Phenyl substituted cyclic ketoenols BAYER CROPSCIENCE AG (DE) 2007-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015664-A1 2,4,6-Phenyl substituted cyclic ketoenols CYP4X1, KDM4E, KCNE1 MEN1 4847/4885KMT2A 321/4885LPAR1 2667/4885
US-20110092368-A1 2,4,6-Phenyl-substituted cyclic ketoenols CYP4X1, KDM4E, PDHX MEN1 4855/4885KMT2A 276/4885LPAR1 2740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.